The XPD Lys751Gln polymorphism has predictive value in colorectal cancer patients receiving oxaliplatin-based chemotherapy: a systemic review and meta-analysis.

Qian, Ying-Ying; Liu, Xin-You; Pei, Dong; Xu, Jia-Li; Shen, Hua; Chen, Xiao-Feng; Liu, Yi-Qian; Shen, Li-Zong; Shu, Yong-Qian

Qian, Ying-Ying; Liu, Xin-You; Pei, Dong; Xu, Jia-Li; Shen, Hua; Chen, Xiao-Feng; Liu, Yi-Qian; Shen, Li-Zong; Shu, Yong-Qian.

Affiliation

Qian YY; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China E-mail : shuyongqian2014@gmail.com.

Asian Pac J Cancer Prev ; 15(22): 9699-706, 2014.

Article in En | MEDLINE | ID: mdl-25520091

Subject(s)

Antineoplastic Agents/therapeutic use; Colorectal Neoplasms/drug therapy; Colorectal Neoplasms/genetics; Organoplatinum Compounds/therapeutic use; Polymorphism, Genetic/genetics; Xeroderma Pigmentosum Group D Protein/genetics; Humans; Oxaliplatin; Prognosis; Risk Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Polymorphism, Genetic / Colorectal Neoplasms / Xeroderma Pigmentosum Group D Protein / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2014 Type: Article

Search on Google

XML

PubMed Links